Over 10+ years of experience in molecular diagnostics industry;
Former HKSTP fund assessment panelist;
Former HKUST research project fund assessment panelist;
Master of Philosophy at the University of Hong Kong;
PhD at the National Institute for Basic Biology, Japan;
Member of Hong Kong Society for Molecular Diagnostic Sciences Ltd

Over two decades of drug discovery and development expertise in pharma and biotech companies including Amgen, ImClone/Lilly, deCODE, Genea Biocells;
diverse modalities in mid/late stages of clinical developments to treat oncology, CNS, metabolic and neuromuscular disorders with specific emphasis on rare diseases;
over 170 peer-reviewed publications and over 60 granted patents and patent applications

Head of Sales & Marketing;
Board Member of numerous Biotechnology companies in Hong Kong and China;
Over 20 years of project management and sales marketing;
BSLA; EMIL; MBA

Biotechnology Scientist;
Former Program Manager, Project Planning and Execution Group, Hong Kong Applied Science and Technology Research Institute Company Limited (ASTRI);
PhD, The Hong Kong Baptist University

Biochemistry Scientist;
Scientific Officer, The Chinese University of Hong Kong;
PhD, GradD, M.Phil., The Chinese University of Hong Kong

Honorary Associate Professor & Research Scientist, the University of Hong Kong;
Former Visiting Professor at University of California, San Francisco,
Baylor Medical College and Medical College of Georgia;
Former Scientist, National Institute of Health;
Founder and President of the Hong Kong Biochemistry Association;
Inventor & Patent Holder of Flow-through Hybridization Technology

Medical oncologist;
Distinguished Professor and Chair, Department of Biochemistry and Molecular Medicine, UC Davis Health School of Medicine;
Sue Jane Leung Presidential Chair in Cancer Research & Harold Albin Johnson Endowed Chair in Biomedical Research, UC Davis NCI-Designated Comprehensive Cancer Center;
PhD in Oncology, McArdle Laboratory for Cancer Research, University of Wisconsin;
MD, Stanford University School of Medicine

Pharmacologist;
Research Scientist, Stanford University;
Honorary Associate Professor, the University of Hong Kong;
President & Founder of Apollonian Biosystems Ltd./ Inc., Hong Kong and USA; Patent Holder;
PhD, & M.S., Yale University;
M.S., Columbia University

Tsao Yen-Chow Endowed Professor & Head, Department of Paediatrics & Adolescent Medicine, the University of Hong Kong;
Chief of Service, Department of Paediatrics & Adolescent Medicine, Hong Kong Children's Hospital, HKU-Shenzhen Hospital & Gleneagles Hospital;
Deputy Director, Stem Cells & Regenerative Medicine Consortium;
Chief Commission Service Coordinator (Paediatric Oncology), Hong Kong Children's Hospital. DMD & MD, the University of the East

Former National Sales & Marketing Director, Bio-Rad Laboratories Canada;
Former Asia-Pacific Chairman & President, PerkinElmer;
Member of the Advisory Council on Food and Environment Hygiene of the HKSAR Government;
Tenth Council member, the Chinese People’s Political Consultative Conference in Jilin province;
Honorary Fellow, the Hong Kong University of Science and Technology

Co-Founder & Co-CEO of MaLogic;
Former Group Chairman, Ogilvy in Hong Kong and Southern China;
Former Council Member of The HK Trade Development Council & The HK Academy for Performing Arts;
Member of the Advisory Committee on Arts Development;
Vetting Committee Member of the SME Development Fund & BUD Fund;
Former Advisory Committee Member for the ICAC, HK Museum, CEDB and the Education Bureau. Vice-Chairman of Plan International (HK);
University Fellowship, the Hong Kong Polytechnic University